SCHEMBL734010

SCHEMBL734010

NCCCC1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18430894 0.97 SIGMAR1 (0.81)
Hydrochloric Acid SCHEMBL7027757 0.97 SIGMAR1 (0.73)
SCHEMBL21944186 0.97 SIGMAR1 (0.81)
SCHEMBL18823182 0.97 SIGMAR1 (0.81)
SCHEMBL128981 0.97 SIGMAR1 (0.81)
SCHEMBL24733023 0.97 SIGMAR1 (0.81)
SCHEMBL10451694 0.97 SIGMAR1 (0.81)
SCHEMBL20821278 0.97 SIGMAR1 (0.81)
SCHEMBL8392554 0.97 SIGMAR1 (0.81)
SCHEMBL21726245 0.95 SIGMAR1 (0.70)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140364566-A1 SCALE-UP PROCESS OF BIFUNCTIONALIZED TRIBLOCK COPOLYMERS WITH SECONDARY AND TERTIARY AMINES, WITH APPLICATION IN DEWATERING AND DESALTING OF HEAVY CRUDE OILS INSTITUTO MEXICANO DEL PETROLEO (MX) 2014-12-11 US claimed
US-20030018045-A1 Heterocyclic beta-3 adrenergic receptor agonists WYETH (US) 2003-01-23 US claimed
US-6451814-B1 SUBSTITUTED 4-((4-AMINO-5-HYDROXYPHENYL)-OXY-)PIPERIDINE ANALOGS; METABOLIC DISORDERS; ANTIDIABETIC AGENTS; ATHERO-SCLEROSIS, GASTROINTESTINAL DISORDERS, GLAUCOMA, NEUROGENETIC INFLAMMATION, OCULAR HYPERTENSION AND FREQUENT URINATION WYETH 2002-09-17 US claimed
US-20020028832-A1 Heterocyclic beta-3 adrenergic receptor agonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-03-07 US claimed
WO-2002006229-A2 HETEROCYCLIC BETA-3 ADRENERGIC RECEPTOR AGONISTS WYETH (US) 2002-01-24 WO claimed
EP-4656602-A2 MEMBRANES FOR REMOVING METALLIC SPECIES FROM AMINES Entegris, Inc. (US) 2025-12-03 EP disclosed
US-20240350984-A1 MEMBRANES FOR REMOVING METALLIC SPECIES FROM AMINES ENTEGRIS, INC. 2024-10-24 US disclosed
CN-115974713-B Fluorine-containing compound, preparation method and compound containing fluorine-containing compound 中国科学技术大学 2024-10-01 CN disclosed
US-12059656-B2 Membranes for removing metallic species from amines ENTEGRIS, INC. (US) 2024-08-13 US disclosed
CN-117946773-A Composition with gasoline cleaning function and preparation method thereof 中国石油化工股份有限公司 2024-04-30 CN disclosed
WO-2023121239-A1 ELECTRONIC DEVICE COMPRISING FLEXIBLE DISPLAY AND DISPLAY SUPPORT STRUCTURE, AND MANUFACTURING METHOD FOR DISPLAY SUPPORT STRUCTURE 삼성전자 주식회사 2023-06-29 WO disclosed
WO-2023120016-A1 METHOD FOR CLEANING SEMICONDUCTOR WAFER AND METHOD FOR PRODUCING SEMICONDUCTOR WAFER 株式会社SUMCO 2023-06-29 WO disclosed
CN-1019113-B Process for preparing 3-arylhydrido-3-substituted propanamines LILLY CO ELI (US) 1992-11-18 CN disclosed
US-5120738-A Cardiovascular disorders FUJIREBIO INC. (JP) 1992-06-09 US disclosed
EP-0421441-A2 Pantothenic acid derivatives FUJIREBIO INC. (JP) 1991-04-10 EP disclosed
CN-87108175-A The propylamine that 3-aryloxy-3-replaces 1988-07-06 CN disclosed
US-4141893-A Decahydrocyclopent[c]azepines ELI LILLY AND COMPANY (US) 1979-02-27 US disclosed
US-4089865-A Certain thiazole compounds SYNTEX (U.S.A.) INC. (US) 1978-05-16 US disclosed
US-4064135-A Certain thiazole-5-carboxamide compounds SYNTEX (U.S.A.) INC. (US) 1977-12-20 US disclosed
US-4001421-A THIAZOLE CARDIOVASCULAR AGENTS SYNTEX (U.S.A.) INC. (US) 1977-01-04 US disclosed